These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R. J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358 [Abstract] [Full Text] [Related]
13. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. Poulin MF, Alexander S, Doukky R. J Nucl Cardiol; 2016 Apr; 23(2):202-11. PubMed ID: 25788401 [Abstract] [Full Text] [Related]
15. Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers. Rai M, Ahlberg AW, Marwell J, Chaudhary W, Savino JA, Alter EL, Henzlova MJ, Duvall WL. J Nucl Cardiol; 2017 Apr; 24(2):724-734. PubMed ID: 26902485 [Abstract] [Full Text] [Related]
16. Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial perfusion imaging? Nair SU, Ahlberg AW, Katten DM, Heller GV. J Nucl Cardiol; 2015 Feb; 22(1):22-35. PubMed ID: 25124828 [Abstract] [Full Text] [Related]
18. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging. Andrikopoulou E, AlJaroudi WA, Farag A, Lester D, Patel H, Iskandrian AE, Hage FG. Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736 [Abstract] [Full Text] [Related]